Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes.
Ginger S CarlsEdward TuttleRuo-Ding TanJohnny HuynhJohn YeeSteven V EdelmanWilliam H PolonskyPublished in: Diabetes care (2017)
Poor medication adherence is primarily why RW effectiveness is significantly less than RCT efficacy, suggesting an urgent need to effectively address adherence among patients with type 2 diabetes.